目的　观察养心氏片剂治疗缺血性脑血管病疗效及安全性。　方法　选择经头颅CT或MRI证实的住院缺血性脑血管病病人 12 0例 ,随机分为治疗组 60例 ,男 3 8例 ,女 2 2例 ,年龄 48岁～ 76岁 ,平均 61岁 ;对照组 60例 ,男 3 6例 ,女 2 4例 ,年龄 45岁～ 76岁 ,平均 60岁。两组均每日 1次丹参注射液 2 0ml + 5%葡萄糖液 2 50ml静脉点滴 ,治疗组另加养心氏片剂 5片口服 ,每日 3次 ,其他常规治疗相同 ,疗程均为 4周。治疗期间观察其疗效及副反应。　结果　治疗前后两组积分比较 :治疗组在治疗后积分比治疗前减少 12 2 3分 (P <0 0 1) ;对照组在治疗后积分比治疗前减少 4 12分 (P >0 0 5) ;治疗后积分两组比较 :治疗组较对照组显著为优 (P <0 0 1) ;总有效率治疗组为 92 3 % ,对照组为 46 7%。未见不良反应。　结论　养心氏片剂治疗缺血性脑血管病疗效好 Objective To observe the efficacy and safety of Yangxin tablets in the treatment of ischemic cerebrovascular disease. Methods A total of 120 hospitalized patients with ischemic cerebrovascular disease confirmed by skull CT or MRI were randomly divided into treatment group (60 cases), 38 males and 22 females, aged from 48 to 76 years (mean, 61 years). The control group of 60 patients, 36 males and 24 females, aged 45 years to 76 years, mean 60 years. Both groups were given once daily Danshen injection 20ml + 5% glucose solution 2 50ml intravenous drip, the treatment group plus Yang Xin tablets 5 oral, 3 times a day, the same as other conventional treatment, the treatment was 4 weeks . Observed during treatment efficacy and side effects. Results Before and after treatment, the scores of the two groups were decreased: the score of the treatment group after treatment decreased by 12 2 3 points (P 0 01); the score of the control group decreased 4 12 points after treatment (P 0 05) ; After treatment, the scores of the two groups were significantly higher in the treatment group than in the control group (P <0.01); the total effective rate was 92.3% in the treatment group and 46.7% in the control group. No adverse reactions. Conclusion Yang Xin tablets in the treatment of ischemic cerebrovascular disease effective